The World Health Organization’s Technical Advisory Group recommended on Wednesday that India’s coronavirus vaccine COVAXIN should be granted emergency use listing status.
The Indian first homegrown COVID-19 vaccine was developed by domestic company Bharat Biotech in collaboration with the country’s Council of Medical Research (ICMR) and the National Institute of Virology (NIV).
The two-dose vaccine has estimated to be 77.8% effective in preventing COVID-19 and 93.4% successful in preventing severe cases of coronavirus infection. The latest studies also determined the jab’s efficacy versus the Delta strain at 65.2%.
The Gazan Ministry of Health announced on Monday that the total number of Palestinians who…
A magnitude 5.5 earthquake struck the Chukotka region of Russia on Monday, according to the…
Despite the significant advances that COVID-19 vaccines represent for public health, especially decreasing hospitalizations and…
The General Directorate of the National Guard has denied reports posted on social networks according…
By:Souleymane Loum | It was Laurent Fabius and the Constitutional Council upon whom President Emmanuel Macron…
According to forecasts from the National Institute of Meteorology (INM), further stormy rainfalls are anticipated…
This website uses cookies.